3.86
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.07
Aprire:
$3.12
Volume 24 ore:
388.18K
Relative Volume:
18.06
Capitalizzazione di mercato:
$25.72M
Reddito:
$105.38M
Utile/perdita netta:
$17.78M
Rapporto P/E:
1.4457
EPS:
2.67
Flusso di cassa netto:
$-50.48M
1 W Prestazione:
+40.36%
1M Prestazione:
+73.09%
6M Prestazione:
+39.60%
1 anno Prestazione:
+37.37%
Mei Pharma Inc Stock (MEIP) Company Profile
Nome
Mei Pharma Inc
Settore
Industria
Telefono
858-369-7100
Indirizzo
11455 EL CAMINO REAL, SAN DIEGO, CA
Confronta MEIP con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MEIP
Mei Pharma Inc
|
3.86 | 18.32M | 105.38M | 17.78M | -50.48M | 2.67 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
469.55 | 123.00B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
547.93 | 59.66B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
322.81 | 41.84B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
577.92 | 33.98B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
279.16 | 27.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Mei Pharma Inc Stock (MEIP) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-07-23 | Downgrade | Laidlaw | Buy → Hold |
2022-03-25 | Downgrade | Jefferies | Buy → Hold |
2022-03-25 | Downgrade | Stifel | Buy → Hold |
2022-03-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2022-02-03 | Iniziato | Jefferies | Buy |
2020-09-22 | Iniziato | Alliance Global Partners | Buy |
2020-05-29 | Iniziato | SunTrust | Buy |
2018-12-20 | Iniziato | H.C. Wainwright | Buy |
2018-07-27 | Aggiornamento | Stifel | Hold → Buy |
2018-07-13 | Iniziato | SunTrust | Buy |
2016-04-18 | Reiterato | Wedbush | Neutral |
2015-03-23 | Downgrade | ROTH Capital | Buy → Neutral |
2014-12-18 | Reiterato | ROTH Capital | Buy |
2014-10-16 | Reiterato | ROTH Capital | Buy |
2014-07-08 | Ripresa | Brean Capital | Buy |
2013-10-22 | Reiterato | Stifel | Buy |
2013-04-15 | Iniziato | Stifel | Buy |
Mostra tutto
Mei Pharma Inc Borsa (MEIP) Ultime notizie
How MEI Pharma Inc. stock performs during market volatilityParabolic Move Ideas - Newser
why mei pharma inc. stock attracts strong analyst attentionVerified Return Tips - Newser
Why MEI Pharma Inc. stock attracts strong analyst attentionGrowth Stock Monitor - Newser
What makes MEI Pharma Inc. stock price move sharplyFree Insider Trading Tips - Newser
MEI Pharma (NASDAQ:MEIP) Shares Cross Below Two Hundred Day Moving Average – What’s Next? - Defense World
Northern Trust Corp Increases Stock Holdings in MEI Pharma, Inc. (NASDAQ:MEIP) - Defense World
Marginal Zone Lymphoma Pipeline Appears Robust With 50+ Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail
MEI Pharma (NASDAQ:MEIP) Coverage Initiated at StockNews.com - Defense World
1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid - The Globe and Mail
MEI Pharma Reports Significant Revenue Decline - TipRanks
MEIP Explores Strategic Options to Enhance Shareholder Value | M - GuruFocus
MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position - GuruFocus
MEI Pharma (NASDAQ:MEIP) Earns Buy Rating from Analysts at StockNews.com - Defense World
This More Than 5%-Yielding Dividend Stock Looks Like a Can't-Miss Buy for Income and Upside Potential - The Globe and Mail
A new MEI study highlights the importance of micro-entrepreneurs in supplying drinking water to poorer neighbourhoods in Ivory Coast - GlobeNewswire Inc.
10 Best NASDAQ Stocks to Buy According to Billionaires - Insider Monkey
Inside Buffett’s $334B Cash Pile: Get Ready for Berkshire Hathaway Earnings - The Globe and Mail
MEI Pharma (NASDAQ:MEIP) Now Covered by StockNews.com - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
StockNews.com Initiates Coverage on MEI Pharma (NASDAQ:MEIP) - Defense World
Follicular Lymphoma Treatment Market 2034: EMA, PDMA, FDA - openPR.com
Follicular Lymphoma Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Medication, Prevalence, Revenue, Statistics and Companies by DelveInsight - The Globe and Mail
Sharp Co. (OTCMKTS:SHCAY) Short Interest Down 25.8% in March - The AM Reporter
11 Best Internet Retail Stocks to Buy According to Analysts - Insider Monkey
Billionaire David Tepper’s Top 10 Stock Picks - Insider Monkey
MEI Pharma (NASDAQ:MEIP) Stock Passes Below Two Hundred Day Moving Average – Here’s What Happened - Defense World
MEI Pharma stock hits 52-week low at $1.83 amid market challenges - Investing.com
MEI Pharma stock hits 52-week low at $1.83 amid market challenges By Investing.com - Investing.com South Africa
MEI PHARMA INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus
Follicular Lymphoma Market to Reach New Heights in Growth - openPR.com
Follicular Lymphoma Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Roche, BeiGene, Kite Pharma, Incyte Corp, AstraZeneca, MEI Pharma, Novartis, Innovent Biologics, Regeneron - Barchart.com
Virtu Financial LLC Purchases Shares of 10,744 MEI Pharma, Inc. (NASDAQ:MEIP) - Defense World
MEI Pharma (NASDAQ:MEIP) Now Covered by Analysts at StockNews.com - The AM Reporter
StockNews.com Begins Coverage on MEI Pharma (NASDAQ:MEIP) - Defense World
MEI Pharma stock hits 52-week low at $2.27 amid market challenges - Investing.com Australia
The Radoff-JEC Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors - Business Wire
MEI Pharma (NASDAQ:MEIP) Coverage Initiated by Analysts at StockNews.com - Defense World
MEI Pharma stock hits 52-week low at $2.28 amid market challenges - Investing.com Australia
MEI Pharma stock hits 52-week low at $2.28 amid market challenges By Investing.com - Investing.com South Africa
Will the Stock Market Crash As President Trump's Tariffs Take Effect? History Offers a Clue. - The Globe and Mail
MEI Pharma, Inc. to Host Earnings Call - ACCESS Newswire
Mei Pharma Inc Azioni (MEIP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):